Abstract
Despite rising rates of macrolide resistance to Streptococcus pneumoniae, the current guidelines for outpatient treatment of community-acquired pneumonia include a macrolide as initial empiric therapy. There have only been a few previously documented cases of macrolide treatment failure in community-acquired pneumonia and there is controversy as to whether macrolide resistance in S. pneumoniae is clinically important. Reported here are two cases of community-acquired pneumonia caused by S. pneumoniae, one of which was fatal, that failed to respond to clarithromycin.
Similar content being viewed by others
References
Jacobs MR (2002) In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure. Clin Infect Dis 35:565–569
Rothermel CD (2004) Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes? Clin Infect Dis 38(Suppl 4):346–349
Lonks JR (2004) What is the clinical impact of macrolide resistance? Current Infect Dis Reports 6:7–12
Nuermberger E, Bishai WR (2004) The clinical significance of macrolide-resistant Streptococcus pneumoniae: it’s all relative. Clin Infect Dis 38:99–103
Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH (2000) Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Infectious Community-Acquired Pneumonia Working Group. Clin Infect Dis 31:383–421
Bartlett JC, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community acquired pneumonia in adults. Clin Infect Dis 31:347–382
Mandell LA, Bartlett JC, Dowell SF, File TM Jr, Musher DM, Whitney C (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37:1405–1433
File TM, Garau J, Blasi F et al (2004) Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest 125:1888–1901
Rzeseszutek M, Wierzbowski A, Hoban DJ, Conly J, Bishai W, Zhanel GG (2004) A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Int J Antimicrob Agents 24:95–104
Lonks JR, Garau J, Gomez L et al (2002) Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 35:556–564
Van Kerkhoven D, Peetermans WE, Verbist L, Verhaegen J (2003) Breakthrough pneumococcal bacteremia in patients with clarithromycin or oral beta-lactams. J Antimicrob Chemother 51:691–696
National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. Approved standard M100 S14. NCCLS, Wayne, PA
Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L (1996) Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40:2562–2566
Farrell DJ, Jenkins SJ, Brown SD, Patel M, Lavin BS, Klugman KP (2005) Emergence and spread of Streptococcus pneumoniae with erm (B) and mef (A) resistance. Emerg Infect Dis 11:851–858
Powis J, McGeer A, Green K et al (2004) In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother 48:3305–3311
Hoban DJ, Wierzbowski AK, Nichol K et al (1998) Macrolide-resistant Streptococcus pneumoniae in Canada during 1998–1999: prevalence of mef (A) and erm (B) and susceptibilities to ketolides. Antimicrob Agents Chemother 45:147–150
Acknowledgements
The authors wish to thank Dr. M. Gerson for reviewing the manuscript. J.D. has been a paid consultant and speaker for Sanofi–Aventis, Bristol–Myers Squibb and Pfizer. R.D. has been a paid consultant and speaker for Sanofi–Aventis, Bristol–Myers Squibb, Abbott Laboratories, Bayer and Roche.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dylewski, J., Davidson, R. Bacteremic pneumococcal pneumonia associated with macrolide failure. Eur J Clin Microbiol Infect Dis 25, 39–42 (2006). https://doi.org/10.1007/s10096-005-0081-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-005-0081-z